Breast Thermography Not Reliable Alternative to Mammography: Study
Breast thermography, also known as digital infrared thermal imaging (DITI), is not considered a reliable alternative to mammography for breast cancer screening. A study of over 10,000 women found that nearly 72% of those who developed breast cancer had normal thermogram results.
Thermography works by detecting heat patterns and blood flow in body tissues using infrared cameras. The idea is that increased blood flow to tumours raises surface temperatures. However, it has a high false-positive rate and can miss breast cancers, similar to mammography. This is why the Food and Drug Administration (FDA) has cleared its use only as an adjunct to mammography or other primary screening tests, not as a standalone tool.
Organizations that provide recommendations for breast cancer early detection, such as Austria's Breast Cancer Early Detection Program (BKFP), German and Austrian cancer societies, and health ministries, promote mammography screening, clinical examinations, and breast self-examinations. They do not recommend thermography as a primary screening method due to its limitations.
Thermography does not emit radiation like mammography, which uses low-dose X-rays. The average cost of a breast thermogram ranges from $175 to $250, and Medicare does not cover it.
In conclusion, while thermography has some potential benefits, it is not a reliable alternative to mammography for breast cancer screening. It is important for women to follow the guidelines set by national breast cancer screening programs and healthcare providers for early detection and diagnosis.
Read also:
- Hospital's Enhancement of Outpatient Services Alleviates Emergency Department Strain
- Increased Chikungunya infections in UK travelers prompt mosquito bite caution
- Kazakhstan's Deputy Prime Minister holds discussions on the prevailing circumstances in Almaty
- In the state, Kaiser Permanente boasts the top-ranked health insurance program
